As the legendary investor Warren Buffett once said, forecasts about the future usually tell you more about the forecaster than they do about the future.
With the pharma industry putting the ‘blockbuster’ age behind it and moving into meeting needs across myriad niche disease areas, what is the impact and therefore change of requirement in terms of